(Alliance News) - AstraZeneca PLC on Monday said the European Commission has approved Enhertu as the first tumour-agnostic HER2-directed therapy and antibody drug conjugate in the EU for previously treated patients with HER2-positive metastatic solid tumours. Read More
(Alliance News) - BT and Verizon form international joint venture, Foresight increases its dividend while Plus500 adds to its US prediction markets offering with sports event-based contracts. Read More
(Alliance News) - AstraZeneca PLC on Friday said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended approval of Datroway for a form of breast cancer. Read More
(Alliance News) - The FTSE 100 edged lower on Tuesday held back by weak miners, while fresh US tech falls and soft UK economic data added to the muted mood. Read More
(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has accepted and granted priority review to a supplemental biologics licence application for Ultomiris as a treatment for adults with immunoglobulin A nephropathy. Read More
(Alliance News) - AstraZeneca PLC on Friday said a Truqap combination has been approved by the US Food & Drug Administration as a first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer. Read More
(Alliance News) - The FTSE 100 ended the week on the front foot as Iran claimed a deal with the US has "never been closer", while investors were glued to dealing screens as trading in SpaceX kicked off. Read More
(Alliance News) - AstraZeneca PLC on Monday announced positive results from the Vista and Solstice phase IIb trials of elecoglipron, an oral small molecule GLP-1 receptor agonist. Read More
(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More
(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, Chief Executive Officer Pascal Soriot told the Financial Times in an interview published on Saturday. Read More
(Alliance News) - The FTSE 100 clung on to modest gains on Friday despite weak mining stocks, but Wall Street headed south after stronger-than-expected jobs data increased chances of a rate hike across the pond. Read More
(Alliance News) - Worldwide Healthcare Trust PLC on Friday said pharma company AstraZeneca PLC was its top contributor to its portfolio performance while surgical equipment firm Stryker Corp was the top detractor. Read More
(Alliance News) - BSF Enterprise on Tuesday saw its shares rise after the publication of a paper on one of its subsidiaries' synthetic leather products. Read More
(Alliance News) - AstraZeneca PLC on Monday posted positive phase-three trial results for a combination of its drugs Imfinzi and Imjudo to treat a form of liver cancer. Read More
